The effect of PAMAM dendrimers on mesenchymal stem cell viability and differentiation

Current Medicinal Chemistry

Volumn 19, Issue 29, 2012, Pages 4969-4975

  Goncalves M ^a   Castro, R ^a   Rodrigues, J ^a   Tomas H ^a  

^a UNIVERSITY OF MADEIRA   (Portugal)

Author keywords

Adipogenesis; Alkaline phosphatase activity; Cell viability; Cytotoxicity; Dendrimer; Differentiation; Human mesenchymal stem cells; Osteogenesis; PAMAM; Poly(amidoamine)

Indexed keywords

CARBOXYLIC ACID; DENDRIMER; HYDROXYL GROUP; POLYAMIDOAMINE;

ADIPOCYTE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSTEOBLAST; PHENOTYPE;

CELL DIFFERENTIATION; CELL SURVIVAL; DENDRIMERS; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84870470994     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311209024969     Document Type: Article

References (34)

1. Teo, A.K.K.; Vallier, L. Emerging use of stem cells in regenerative medicine. Biochem. J., 2010, 428, 11-23.
2. Sakurada, K.; McDonald, F.M.; Shimada, F. Regenerative medicine and stem cell based drug discovery. Angew. Chem. Int. Ed., 2008, 47, 5718-5738.
3. Parekkadan, B.; Milwid, J.M. Mesenchymal Stem Cells as Therapeutics. Annu. Rev. Biomed. Eng., 2010, 12, 87-117.
4. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.C.; Krause, D.S.; Deans, R.J.; Keating, A.; Prockop, D.J.; Horwitz, E.M. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society fo Cellular Therapy position statement. Cytotherapy, 2006, 8, 315-317.
5. Bianco, P.; Robey, P.G.; Simmons, P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell, 2008, 2, 313-319.
6. Lyssiotis, C.A.; Lairson, L.L.; Boitano, A.E.; Wurdak, H.; Zhu, S.; Schultz, PG. Chemical control of stem cell fate and developmental potential. Angew. Chem. Int. Ed., 2011, 50, 200-242.
7. Gao, J.; Xu, B. Applications of nanomaterials inside cells. Nano Today, 2009, 4, 37-51.
8. Riehemann, K.; Schneider, S.W.; Luger, T.A.; Godin, B.; Ferrari, M.; Fuchs, H. Nanomedicine - challenge and perspectives. Angew. Chem. Int. Ed., 2009, 48, 872-897.
9. Solanki, A.; Kim, J.D.; Lee, K.-B. Nanotechnology for regenerative medicine: nanomaterials for stem cell imaging. Nanomedicine, 2008, 3, 567-578.
10. Mintzer, M.A.; Simanek, E.E. Nonviral vectors for gene delivery. Chem. Rev., 2009, 109, 259-302.
11. Svenson, S.; Tomalia, D.A. Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev., 2005, 57, 2106-2129.
12. Astruc, D.; Boisselier, E.; Ornelas, C. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, and nanomedicine. Chem. Rev., 2010, 110, 1857-1959.
13. Santos, J.L.; Oramas, E.; Pêgo, A.P.; Granja, P.L.; Tomás, H. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. J. Control. Release, 2009, 134, 141-148.
14. Pandita, D.; Santos, J.L.; Rodrigues, J.; Pêgo, A.P.; Granja, P.L.; Tomás, H. Delivery of the BMP-2 gene into MSCs: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers. Biomacromolecules, 2011, 12, 472-481.
15. Shakhbazau, A.; Shcharbin, D.; Seviaryn, I.; Goncharova, N.; Kosmacheva, S.; Potapnev, M.; Gabara, B.; Ionov, M.; Bryszewska, M. Use of polyamidoamine dendrimers to engineer BDNF-producing human mesenchymal stem cells. Mol. Biol. Rep., 2010, 37, 2003-2008.
16. Shakhbazau, A.; Shcharbin, D.; Petyovka, N.; Goncharova, N.; Seviaryn, I.; Kosmacheva, S.; Bryszewska, M.; Potapnev, M. Non-virally modified human mesenchymal stem cells produce ciliary neurotrophic factor in biodegradable fibrin-based 3D scaffolds. J. Pharm. Sci., 2012, 101, 1546-1554.
17. Santos, J.L.; Pandita, D.; Rodrigues, J.; Pêgo, A.P.; Granja, P.L.; Balian, G.; Tomás, H. Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells. Mol. Pharmaceutics, 2010, 7, 763-774.
18. Santos, J.L.; Oliveira, H.; Pandita, D.; Rodrigues, J.; Pêgo, A.P.; Granja, P.L.; Tomás, H. Functionalization of Poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J. Control. Rel., 2010, 144, 55-64.
19. Higuchi, Y.; Wu, C.; Chang, K.-L.; Irie, K.; Kawakami, S.; Yamashita, F.; Hashida, M. Polyamidoamine dendrimer-conjugated quantum dots for efficient labeling of primary cultured mesenchymal stem cells. Biomaterials, 2011, 32, 6676-6682.
20. Oliveira, J.M.; Sousa, R.A.; Kotobuki, N.; Tadokoro, M.; Hirose, M.; Mano, J.F.; Reis, R.L.; Ohgushi, H. The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/ poly(amidoamine) dendrimer nanoparticles. Biomaterials, 2009, 30, 804-813.
21. Oliveira, J.M.; Kotobuki, N.; Marques, A.P,; Pirraco, R.P.; Benesch, J.; Hirose, M.; Costa, S.A.; Mano, J.F.; Ohgushi, H.; Reis, R.L. Surface engineered carboxymethyl-chitosan/poly(amidoamine) dendrimer nanoparticles for intracellular targeting. Adv. Func. Mater., 2008, 18, 1840 - 1853.
22. Hong, L.; Krishnamachari, Y.; Seabold, D.; Joshi, V.; Schneider, G.; Salem, A.K. Intracellular release of 17-estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic differentiation of human mesenchymal stromal cells. Tissue Eng. Part C Methods, 2011, 17, 319-325.
23. Labieniec, M.; Watala, C. PAMAM dendrimers - diverse biomedical applications. Facts and unresolved questions. Cent. Eur. J. Biol., 2009, 4, 434-451.
24. Jain, K.; Kesharwani, P.; Gupta, U.; Jain, N.K. Dendrimer toxicity: Let's meet the challenge. Int. J. Pharm., 2010, 394,122-142.
25. Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J.W.; Meijer, E.W.; Paulus, W.; Duncan, R. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J. Control. Release, 2000, 65, 133-48.
26. Agashe, H.B.; Dutta, T.D.; Garg, M.; Jain, N.K. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. J. Pharm. Pharmacol., 2006, 58, 1491-1498.
27. Jevprasesphant, R.; Penny, J.; Jalal, R.; Attwood, D.; McKeown, N.; D'Emanuele, A. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int. J. Pharm., 2003, 252, 263-266.
28. Chen, H.T.; Neerman, M.F.; Parrish, A.R.; Simanek, E. Cytotoxicity, haemolysis, and acute in vivo toxicity of dendrimer based on melamine, candidate vehicles for drug delivery. J. Am. Chem. Soc., 2004, 126, 10044-10048.
29. Roberts, J.C.; Bhalgat, M.K.; Zera, R.T. Preliminary biological evaluation of polyaminoamine (PAMAM) starburst dendrimers. J. Biomed. Mater. Res., 1996, 30, 53-65.
30. Coller, H.A.; Sang, L.; Roberts, J.M. A New Description of cellular quiescence. PLoS Biol., 2006, 4, e83.
31. Klajnert, B.; Stanisławska, L.; Bryszewska, M.; Pałecz, B. Interactions between PAMAM dendrimers and bovine serum albumin. Biochim. Biophys. Acta, 2003, 1648, 115-26.
32. Hong, S.; Leroueil, P.R.; Janus, E.K., Peters; J.L., Kober, M.M.; Islam, M.T.; Orr, B.G., Baker Jr.; J.R., Holl, M.M.B. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjugate Chem., 2006, 17, 728-734.
33. Leroueil, P.R.; Berry, S.A.; Duthie, K.; Han, G.; Rotello, V.M.; McNerny, D.Q.; Baker Jr., J.R.; Orr, B.G.; Holl, M.M. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett., 2008, 8, 420-424.
34. Wang, Z.; Ruan, J.; Cui, D. Advances and Prospect of nanotechnology in stem cells. Nanoscale Res. Lett., 2009, 4, 593-605.